David Boulware

7.9k total citations
122 papers, 5.4k citations indexed

About

David Boulware is a scholar working on Surgery, Oncology and Genetics. According to data from OpenAlex, David Boulware has authored 122 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 36 papers in Oncology and 31 papers in Genetics. Recurrent topics in David Boulware's work include Diabetes and associated disorders (26 papers), Diabetes Management and Research (23 papers) and Pancreatic function and diabetes (22 papers). David Boulware is often cited by papers focused on Diabetes and associated disorders (26 papers), Diabetes Management and Research (23 papers) and Pancreatic function and diabetes (22 papers). David Boulware collaborates with scholars based in United States, Canada and United Kingdom. David Boulware's co-authors include Domenico Coppola, Timothy J. Yeatman, Steven A. Eschrich, Lori Hazlehurst, Craig A. Beam, Jay M. Sosenko, Carla J. Greenbaum, Jay S. Skyler, Jeffrey P. Krischer and Gregory Bloom and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David Boulware

121 papers receiving 5.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Boulware 1.7k 1.6k 1.5k 1.3k 1.0k 122 5.4k
Clara C. Chen 2.6k 1.5× 1.2k 0.8× 3.3k 2.2× 670 0.5× 1.9k 1.9× 99 8.9k
Maurizio Martini 1.0k 0.6× 2.3k 1.5× 1.9k 1.3× 234 0.2× 684 0.7× 281 6.5k
L. Campion 912 0.5× 2.2k 1.4× 1.9k 1.3× 229 0.2× 604 0.6× 185 6.2k
Eleni Efstathiou 615 0.4× 2.0k 1.3× 2.4k 1.6× 794 0.6× 913 0.9× 203 7.4k
Andrew Protheroe 954 0.6× 1.8k 1.2× 1.4k 0.9× 362 0.3× 865 0.9× 124 6.0k
Evan Y. Yu 1.6k 0.9× 1.4k 0.9× 2.4k 1.6× 304 0.2× 417 0.4× 294 5.9k
Lori A. Erickson 1.1k 0.7× 1.5k 1.0× 2.3k 1.5× 568 0.5× 1.6k 1.6× 185 5.5k
Lance C. Pagliaro 2.1k 1.2× 1.6k 1.0× 2.1k 1.4× 287 0.2× 201 0.2× 199 5.9k
Jaime Prat 2.7k 1.6× 3.9k 2.5× 2.9k 1.9× 1.1k 0.9× 376 0.4× 252 14.4k
C Parmentier 1.4k 0.8× 747 0.5× 1.1k 0.7× 677 0.5× 3.1k 3.1× 154 4.7k

Countries citing papers authored by David Boulware

Since Specialization
Citations

This map shows the geographic impact of David Boulware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Boulware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Boulware more than expected).

Fields of papers citing papers by David Boulware

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Boulware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Boulware. The network helps show where David Boulware may publish in the future.

Co-authorship network of co-authors of David Boulware

This figure shows the co-authorship network connecting the top 25 collaborators of David Boulware. A scholar is included among the top collaborators of David Boulware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Boulware. David Boulware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tafreshi, Narges K., Darpan N. Pandya, Mikalai M. Budzevich, et al.. (2021). Lipophilicity Determines Routes of Uptake and Clearance, and Toxicity of an Alpha-Particle-Emitting Peptide Receptor Radiotherapy. ACS Pharmacology & Translational Science. 4(2). 953–965. 21 indexed citations
2.
Kim, Baek‐hui, Bence Kővári, Hayeon Kim, et al.. (2021). Comparative molecular subtypes of index and metachronous gastric adenocarcinomas: a study of 42 Korean patients. Modern Pathology. 34(9). 1728–1737. 2 indexed citations
3.
Manley, Brandon J., Michael Poch, G. Daniel Grass, et al.. (2020). Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis. Advances in Radiation Oncology. 5(5). 905–909. 4 indexed citations
4.
Sims, Emily K., Susan Geyer, Suzanne Bennett Johnson, et al.. (2019). Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention. Diabetes Care. 42(12). 2228–2236. 24 indexed citations
5.
Ruff, Samantha M., Luke D. Rothermel, Laurence P. Diggs, et al.. (2019). Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection. HPB. 22(7). 1004–1010. 9 indexed citations
6.
Shahid, Mohd, James J. Saller, David Boulware, et al.. (2019). FGD4 (Frabin) Overexpression in Pancreatic Neuroendocrine Neoplasms. Pancreas. 48(10). 1307–1311. 6 indexed citations
7.
Leone, Andrew, Kamran Zargar‐Shoshtari, Gregory Diorio, et al.. (2017). Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience. Clinical Genitourinary Cancer. 15(4). e583–e589. 12 indexed citations
8.
Bingley, Polly J., Lisa Rafkin, Della Matheson, et al.. (2015). Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study. Diabetes Technology & Therapeutics. 17(12). 867–871. 16 indexed citations
9.
Greenbaum, Carla J., Craig A. Beam, David Boulware, et al.. (2013). Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data. Diabetes Technology & Therapeutics. 15. 12 indexed citations
10.
Beam, Craig A., Shaobing Li, Raphael P. Viscidi, et al.. (2013). Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. Journal of Clinical Virology. 57(2). 115–119. 23 indexed citations
11.
Greenbaum, Carla J., Craig A. Beam, David Boulware, et al.. (2012). Fall in C-Peptide During First 2 Years From Diagnosis. Diabetes. 61(8). 2066–2073. 235 indexed citations
12.
Extermann, Martine, Edward J. Crane, & David Boulware. (2010). Cancer in nonagenarians: Profile, treatments and outcomes. Critical Reviews in Oncology/Hematology. 75(2). 160–164. 20 indexed citations
13.
Yarde, Danielle N., Vasco Oliveira, Linda Mathews, et al.. (2009). Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma. Cancer Research. 69(24). 9367–9375. 90 indexed citations
14.
Metro, Giulio, Zhong Zheng, Alessandra Fabi, et al.. (2009). In SituProtein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy. Cancer Investigation. 28(2). 172–180. 23 indexed citations
15.
Eschrich, Steven A., Jimmy Pramana, Haiyan Zhang, et al.. (2008). A robust multigene expression assay to predict clinical response to chemoradiotherapy. Clinical Cancer Research. 14. 1 indexed citations
16.
Zheng, Zhong, Xueli Li, Michael J. Schell, et al.. (2008). Thymidylate synthase in situ protein expression and survival in stage I nonsmall‐cell lung cancer. Cancer. 112(12). 2765–2773. 54 indexed citations
17.
Saglam, Ozlen, Christopher R. Garrett, David Boulware, et al.. (2007). Activation of the Serine/Threonine Protein Kinase AKT During the Progression of Colorectal Neoplasia. Clinical Colorectal Cancer. 6(9). 652–656. 17 indexed citations
18.
Nasir, Aejaz, Hans Kaiser, David Boulware, et al.. (2004). Cyclooxygenase-2 Expression in Right- and Left-Sided Colon Cancer: A Rationale For Optimization of Cyclooxygenase-2 Inhibitor Therapy. Clinical Colorectal Cancer. 3(4). 243–247. 23 indexed citations
19.
Pendas, Solange, Ni Ni Ku, Douglas S. Reintgen, et al.. (1999). Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Node. Annals of Surgical Oncology. 6(1). 95–101. 72 indexed citations
20.
Bass, Siddharth S., et al.. (1999). Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma. Annals of Surgical Oncology. 6(6). 553–561. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara C. Chen Breakdown of academic impact, for papers by Maurizio Martini Breakdown of academic impact, for papers by L. Campion Breakdown of academic impact, for papers by Eleni Efstathiou Breakdown of academic impact, for papers by Andrew Protheroe Breakdown of academic impact, for papers by Evan Y. Yu Breakdown of academic impact, for papers by Lori A. Erickson Breakdown of academic impact, for papers by Lance C. Pagliaro Breakdown of academic impact, for papers by Jaime Prat Breakdown of academic impact, for papers by C Parmentier
Rankless by CCL
2026